Bronchiolitis versus bronchopneumonia: navigating antibiotic use within the LRTI spectrum

Area of Science:

• Pediatrics
• Infectious Diseases
• Pharmacology

Background:

• Bronchiolitis is a frequent cause of infant hospitalization in South Africa, often viral.
• Hospitalized infants may present with severe disease, comorbidities, and potential bacterial co-infection requiring antibiotics.
• Widespread antimicrobial resistance in South Africa necessitates careful antibiotic stewardship.

Purpose of the Study:

• To identify common clinical errors in diagnosing bronchopneumonia in infants with bronchiolitis.
• To provide guidance on appropriate antibiotic therapy for hospitalized infants with bronchiolitis in South Africa.
• To advocate for judicious antibiotic use in the context of antimicrobial resistance.

Main Methods:

• This is a commentary, not an original research study.
• It reviews common clinical pitfalls in diagnosis.
• It discusses considerations for antibiotic therapy based on existing knowledge and clinical experience.

Main Results:

• Common diagnostic errors can lead to incorrect bronchopneumonia diagnoses.
• Antibiotic therapy should only be initiated when bacterial co-infection is strongly suspected.
• Prompt discontinuation of antibiotics is recommended if bacterial co-infection is unlikely.

Conclusions:

• A pragmatic management strategy is proposed for antibiotic use in hospitalized South African infants with suspected bacterial co-infection in bronchiolitis.
• Clear indications for antibiotic use and timely cessation are crucial.
• Further data are needed to refine management strategies.